ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT00420888 · COMPLETED

Trial details

NCT number: NCT00420888
Sponsor: Active Biotech AB
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2007-01-01
Primary completion: 2013-01-01
Enrollment: 526

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.